286 related articles for article (PubMed ID: 20425022)
1. New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.
Schlesinger N
Curr Rheumatol Rep; 2010 Apr; 12(2):130-4. PubMed ID: 20425022
[TBL] [Abstract][Full Text] [Related]
2. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
Ernst ME; Fravel MA
Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
[TBL] [Abstract][Full Text] [Related]
3. [New therapeutic options for gout].
Richette P; Ottaviani S; Bardin T
Presse Med; 2011 Sep; 40(9 Pt 1):844-9. PubMed ID: 21684104
[TBL] [Abstract][Full Text] [Related]
4. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
5. Febuxostat (Uloric) for chronic treatment of gout.
Med Lett Drugs Ther; 2009 May; 51(1312):37-8. PubMed ID: 19448587
[TBL] [Abstract][Full Text] [Related]
6. Advances in pharmacotherapy for the treatment of gout.
Robinson PC; Dalbeth N
Expert Opin Pharmacother; 2015 Mar; 16(4):533-46. PubMed ID: 25547991
[TBL] [Abstract][Full Text] [Related]
7. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
Chaichian Y; Chohan S; Becker MA
Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
[TBL] [Abstract][Full Text] [Related]
8. Febuxostat: a new agent for lowering serum urate.
Keenan RT; Pillinger MH
Drugs Today (Barc); 2009 Apr; 45(4):247-60. PubMed ID: 19499090
[TBL] [Abstract][Full Text] [Related]
9. Update on emerging urate-lowering therapies.
Chohan S; Becker MA
Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
[TBL] [Abstract][Full Text] [Related]
10. Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.
Curiel RV; Guzman NJ
Semin Arthritis Rheum; 2012 Oct; 42(2):166-78. PubMed ID: 22560299
[TBL] [Abstract][Full Text] [Related]
11. Progress in the pharmacotherapy of gout.
Sundy JS
Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
13. Febuxostat.
Hair PI; McCormack PL; Keating GM
Drugs; 2008; 68(13):1865-74. PubMed ID: 18729537
[TBL] [Abstract][Full Text] [Related]
14. Clinical inquiry: Which prophylactic therapies best prevent gout attacks?
White S; Mounsey A; Tillett J
J Fam Pract; 2014 Apr; 63(4):216, 221. PubMed ID: 24905127
[No Abstract] [Full Text] [Related]
15. Pegloticase for treating refractory chronic gout.
George RL; Sundy JS
Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
[TBL] [Abstract][Full Text] [Related]
16. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
[TBL] [Abstract][Full Text] [Related]
17. Pegloticase for treatment of tophaceous polyarticular gout.
Seifried RM; Roberts J
Hawaii J Med Public Health; 2013 Jul; 72(7):220-3. PubMed ID: 23901393
[TBL] [Abstract][Full Text] [Related]
18. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
19. Treatment failure gout.
Ali S; Lally EV
Med Health R I; 2009 Nov; 92(11):369-71. PubMed ID: 19999896
[No Abstract] [Full Text] [Related]
20. Uricase and other novel agents for the management of patients with treatment-failure gout.
Sundy JS; Hershfield MS
Curr Rheumatol Rep; 2007 Jun; 9(3):258-64. PubMed ID: 17531181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
